Skip to main content
. 2016 Jan 18;75(3):388–401. doi: 10.1111/aji.12483

Figure 2.

Figure 2

Study design. The study was conducted by three sets of contributors. MatriceLab Innove (MLI) designed the study, performed the endometrial immune profile (with its molecular analyses and CD56+ cell count), suggested personalized care, and remained in contact with physicians to follow‐up each IVF/ICSI attempt. Physicians recruited patients, performed the endometrial biopsies, and provided the personalized care before and after performing the IVF/ICSI. The Centre de pathologie (Passy, France) conducted the histological dating of the biopsies and the CD56 immunohistochemistry (IHC).